Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Lymphoma × Thiotepa × Clear all

Phase

Status

Sponsor Class

OTHER 25 NIH 3 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Hodgkin Disease 1

Interventions

Vinorelbine 3 Gemcitabine 3 Ifosfamide 2 pegylated granulocyte colony-stimulating factor 1 pegfilgrastim 1 fludarabine phosphate 1 fludarabine 1 entecavir 1 Thiotepa 1 Rituximab 1 Platelet Transfusion 1 Mind-Body Therapies 1 Etoposide 1 Drug Therapy 1 Dietary Supplements 1 Cytarabine 1 Cyclophosphamide 1 Acupuncture Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03346096 2024-07-09

TEAM

Sheba Medical Center

Phase 2 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡